Octave Announces Publication of Analytical Validation Study Results in Nature Communications More

Recent Announcements & Press

Octave® Bioscience, Inc. Announces Publication of Clinical Validation Study Results of its Novel, Multivariate Multiple Sclerosis Disease Activity (MSDA) Blood Test – Businesswire

Octave’s Solution for Transforming the Care Paradigm in MS has been Selected as a Finalist in Fast Company’s 2023 Innovation by Design Awards

Octave Bioscience Closes $30M Extension to Series B Funding, Adds New Strategic Investors Following Strong Growth and Momentum – Businesswire

Octave Note

Media Library

living well

Diet & Multiple Sclerosis

living well

Multiple Sclerosis: Cause & Cure

living well

The Alldus Podcast – AI in Action